ROYAL BANK OF CANADA - KAZIA THERAPEUTICS LTD ownership

Back to all holdings Add to watchlist

KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 11 filers reported holding KAZIA THERAPEUTICS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of KAZIA THERAPEUTICS LTD
ValueSharesWeighting
Q2 2022$4,000
-50.0%
1,0000.0%0.00%–
Q1 2022$8,000
+700.0%
1,000
+1751.9%
0.00%–
Q3 2021$1,000
-75.0%
54
-95.7%
0.00%–
Q2 2018$4,000
-42.9%
1,2500.0%0.00%–
Q1 2018$7,000
+75.0%
1,2500.0%0.00%–
Q4 2017$4,000–1,250–0.00%–
 Download
Other shareholders
KAZIA THERAPEUTICS LTD shareholders Q3 2022
NameSharesValueWeighting ↓
NewEdge Advisors, LLC 500$5150.00%
BANK OF AMERICA CORP /DE/ 200$2060.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 199,450$205,4530.00%
ACADIAN ASSET MANAGEMENT LLC 68,224$700.00%
Steward Partners Investment Advisory, LLC 25$260.00%
AdvisorNet Financial, Inc 5$50.00%
Belpointe Asset Management LLC 3,000$3,0900.00%
Allworth Financial LP 87$900.00%
View complete list of KAZIA THERAPEUTICS LTD shareholders